These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26884051)

  • 1. 99mTc-MIBI scintigraphy in the diagnosis of multiple myeloma.
    Chrabański O; Gołąb T; Derejczyk M; Pacwa-Bracik K
    Pol Arch Med Wewn; 2016; 126(3):190-2. PubMed ID: 26884051
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
    Look RM; Lim SW; Waxman AD; Gupta PK; Fuerst MM; Kusuanco DA; Lawrence GN; Giles FJ
    Leuk Lymphoma; 1996 Feb; 20(5-6):453-6. PubMed ID: 8833402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active myeloma lesions after high-dose chemotherapy and autologous stem cell transplantation.
    Svaldi M; Tappa C; Gebert U; Bettini D; Fabris P; Franzelin F; Osele L; Mitterer M
    Ann Hematol; 2001 Jul; 80(7):393-7. PubMed ID: 11529464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience.
    Villa G; Balleari E; Carletto M; Grosso M; Clavio M; Piccardo A; Rebella L; Tommasi L; Morbelli S; Peschiera F; Gobbi M; Ghio R
    J Exp Clin Cancer Res; 2005 Sep; 24(3):355-61. PubMed ID: 16270521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison between traditional skeletal radiography and total body bone scintigraphy in the diagnosis of multiple myeloma].
    Scutellari PN; Spanedda R; Feggi LM; Calzolari F; Cervi PM
    Radiol Med; 1984 May; 70(5):271-6. PubMed ID: 6531460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple lytic lesions in multiple myeloma.
    Yulidar ; Susilo A; Cahyanur R; Gaol DL; Rinaldi I
    Acta Med Indones; 2010 Jul; 42(3):169-70. PubMed ID: 20724772
    [No Abstract]   [Full Text] [Related]  

  • 7. Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake.
    Nandurkar D; Kalff V; Turlakow A; Spencer A; Bailey MJ; Kelly MJ
    Eur J Haematol; 2006 Feb; 76(2):141-6. PubMed ID: 16405435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of novel agents followed by autologous hematopoietic stem cell transplantation for multiple myeloma patients aged 65 years or older: a retrospective single Institutional analysis.
    Minoia C; Pisapia G; Palazzo G; Ingrosso C; Buonanno M; Spinosa C; Prudenzano A; Pricolo G; Mazza P
    Bone Marrow Transplant; 2015 Nov; 50(11):1486. PubMed ID: 26281030
    [No Abstract]   [Full Text] [Related]  

  • 9. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
    Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
    Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma.
    Cavo M; Pantani L; Pezzi A; Petrucci MT; Patriarca F; Di Raimondo F; Marzocchi G; Galli M; Montefusco V; Zamagni E; Gamberi B; Tacchetti P; Brioli A; Palumbo A; Sonneveld P
    Leukemia; 2015 Dec; 29(12):2429-31. PubMed ID: 26442610
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiography and bone scintigraphy in multiple myeloma: a comparative analysis.
    Ludwig H; Kumpan W; Sinzinger H
    Br J Radiol; 1982 Mar; 55(651):173-81. PubMed ID: 7066617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
    Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
    Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional outcomes and height restoration for patients with multiple myeloma-related osteolytic vertebral compression fractures treated with kyphoplasty.
    Julka A; Tolhurst SR; Srinivasan RC; Graziano GP
    J Spinal Disord Tech; 2014 Aug; 27(6):342-6. PubMed ID: 22668752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F-FDG PET/CT and 99mTc-MIBI scintigraphy in evaluation of patients with multiple myeloma and monoclonal gammopathy of unknown significance: comparison of methods].
    Myslivecek M; Bacovský J; Scudla V; Koranda P; Minarík J; Buriánková E; Formánek R; Zapletalová J
    Klin Onkol; 2010; 23(5):325-31. PubMed ID: 21061682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of psoriasis after autologous stem cell transplantation - until when?
    Azevedo A; Gonçalves C; Selores M; Torres T
    Eur J Dermatol; 2017 Feb; 27(1):74-75. PubMed ID: 27748257
    [No Abstract]   [Full Text] [Related]  

  • 16. Bortezomib in combination with thalidomide and dexamethasone--a successful treatment regimen in refractory extramedullary multiple myeloma.
    Dytfeld D; Matuszak M; Lewandowski K; Komarnicki M
    Ann Hematol; 2008 Mar; 87(3):253-4. PubMed ID: 17955241
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
    Patriarca F; Prosdocimo S; Tomadini V; Vasciaveo A; Bruno B; Fanin R
    Haematologica; 2005 Feb; 90(2):278-9. PubMed ID: 15710593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
    Pace L; Catalano L; Del Vecchio S; De Renzo A; Fonti R; Salvatore B; Andretta C; Di Nuzzo C; Rotoli B; Salvatore M
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):281-5. PubMed ID: 16172574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.